# NeuroShield (Ginkgo biloba extract)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/neuroshield
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Ginkgo biloba extract, Standardized ginkgo extract, GBE, Ginkgo leaf extract, Maidenhair tree extract, Ginkgo biloba L. extract, EGb, Purified ginkgo extract

## Overview

Ginkgo biloba extract, standardized to 24% flavonol glycosides and 6% terpene lactones (ginkgolides and bilobalide), supports [cognitive function](/ingredients/condition/cognitive) by improving cerebral blood flow and protecting neurons from oxidative damage. Its primary bioactives inhibit platelet-activating factor and scavenge [free radical](/ingredients/condition/antioxidant)s, making it one of the most clinically studied botanical extracts for brain health.

## Health Benefits

• Neuronal cell protection - purified Ginkgo extracts noted for protective activity (evidence quality not specified in available research)
• [Cognitive](/ingredients/condition/cognitive) support - category classification suggests cognitive benefits but specific clinical evidence not detailed in provided sources
• Standardized bioactive content - ensures consistent delivery of flavonol glycosides and terpene trilactones
• Reduced toxin exposure - ginkgolic acids minimized to ≤5 ppm through advanced purification
• Note: Specific clinical benefits for NeuroShield not documented in available research dossier

## Mechanism of Action

Ginkgo biloba extract exerts its effects primarily through two compound classes: flavonol glycosides (quercetin, kaempferol, isorhamnetin) that neutralize [reactive oxygen species](/ingredients/condition/antioxidant) and protect neuronal membranes, and terpene lactones (ginkgolide A, B, C and bilobalide) that antagonize platelet-activating factor (PAF) receptors, reducing platelet aggregation and improving microcirculatory flow to the brain. Bilobalide also modulates GABA-A receptor activity and has been shown to inhibit neuronal apoptosis by preserving [mitochondrial](/ingredients/condition/energy) membrane potential. Collectively, these mechanisms reduce ischemia-related neuronal damage and support cholinergic neurotransmission relevant to [memory](/ingredients/condition/cognitive) consolidation.

## Clinical Summary

Multiple randomized controlled trials using the standardized EGb 761 extract at 120–240 mg/day have demonstrated modest but statistically significant improvements in cognitive composite scores in adults with mild cognitive impairment; a Cochrane review of 36 trials found consistent but heterogeneous evidence supporting memory and attention benefits. A large 3,069-participant RCT (GEM Study, JAMA 2008) found that 120 mg twice daily did not significantly reduce the incidence of dementia over 6.1 years in older adults, tempering earlier enthusiasm. Smaller trials (n=40–200) in healthy younger adults show improvements in [working memory](/ingredients/condition/cognitive) reaction time of approximately 10–15% versus placebo at 240 mg doses. Overall evidence quality is moderate; benefits appear most consistent in populations with existing cognitive decline rather than healthy young adults.

## Nutritional Profile

{"macronutrients": {"protein": "Negligible", "fiber": "Negligible"}, "micronutrients": {"vitamins": "Not specified", "minerals": "Not specified"}, "bioactive_compounds": {"flavonol_glycosides": "24% of extract", "terpene_trilactones": "6% of extract"}, "bioavailability_notes": "Standardized extracts ensure consistent delivery of active compounds, though individual absorption may vary."}

## Dosage & Preparation

No clinically studied dosage ranges for NeuroShield are specified in the available research. The extract has a drug extract ratio of 35-67:1 with standardization focusing on 22-27% flavonol glycosides and 5-7% terpene lactones. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ginkgo biloba is generally well tolerated at 120–240 mg/day, with the most commonly reported adverse effects being mild gastrointestinal upset, headache, and dizziness occurring in roughly 5–7% of users. Due to its PAF-antagonist and antiplatelet properties, it carries a clinically significant interaction risk with anticoagulants (warfarin, heparin) and antiplatelet drugs (aspirin, clopidogrel), potentially increasing bleeding risk; co-administration should be avoided or closely monitored. Ginkgo may also reduce the efficacy of anticonvulsants such as valproate and has been associated with seizure threshold lowering in rare case reports, particularly with unprocessed leaf preparations containing ginkgolic acids. It is not recommended during pregnancy or breastfeeding due to insufficient safety data and theoretical antiplatelet effects on fetal circulation.

## Scientific Research

The research dossier indicates that while EGb 761 (a comparable standardized Ginkgo extract) has been studied clinically, specific study designs, sample sizes, outcomes, and PubMed PMIDs are not available in the provided sources. No clinical trials or meta-analyses for NeuroShield specifically are documented in the research materials.

## Historical & Cultural Context

No historical context, traditional medicine systems, or traditional use information for Ginkgo biloba or NeuroShield is provided in the available research sources.

## Synergistic Combinations

Information on synergistic ingredients not available in research dossier

## Frequently Asked Questions

### What is the recommended dosage of Ginkgo biloba extract for memory support?

The most clinically studied dose for cognitive support is 120–240 mg per day of standardized EGb 761 extract, divided into two or three doses taken with meals. This extract is standardized to 24% flavonol glycosides and 6% terpene lactones to ensure consistent bioactive delivery. Most trials showing cognitive benefit ran for a minimum of 12 weeks before significant effects were observed.

### Can Ginkgo biloba interact with blood thinners like warfarin?

Yes, Ginkgo biloba has a well-documented interaction with warfarin and other anticoagulants because its ginkgolide B component is a potent platelet-activating factor (PAF) antagonist that independently inhibits platelet aggregation. Combining it with warfarin, aspirin, or clopidogrel can significantly elevate bleeding risk, and multiple case reports have linked concurrent use to spontaneous bleeding events. Anyone taking anticoagulant or antiplatelet therapy should consult a physician before using Ginkgo.

### How long does it take for Ginkgo biloba to work?

Clinical trials consistently show that meaningful cognitive improvements with Ginkgo biloba extract typically require at least 4–12 weeks of daily supplementation at 120–240 mg. Acute single-dose studies at 240 mg have shown modest improvements in working memory speed within 4–6 hours, but sustained benefits on memory consolidation and attention require prolonged use. Individual response varies based on baseline cognitive status, with those experiencing mild cognitive decline generally showing more measurable improvements than healthy adults.

### Does Ginkgo biloba actually prevent dementia or Alzheimer's disease?

The large-scale GEM Study (n=3,069, JAMA 2008) found that 240 mg/day of EGb 761 over 6.1 years did not significantly reduce the incidence of all-cause dementia or Alzheimer's disease in older adults compared to placebo. However, smaller trials and meta-analyses suggest Ginkgo may slow the rate of cognitive decline in people already diagnosed with mild-to-moderate dementia. Current scientific consensus is that Ginkgo is not proven to prevent dementia onset but may offer symptomatic support in existing cases.

### What is the difference between Ginkgo biloba leaf and standardized Ginkgo extract?

Raw Ginkgo biloba leaf and non-standardized preparations contain variable levels of bioactives including potentially harmful ginkgolic acids, which are nephrotoxic and allergenic and are limited to under 5 ppm in pharmaceutical-grade extracts like EGb 761. Standardized extracts guarantee 24% flavonol glycosides and 6% terpene lactones per dose, ensuring the therapeutic compounds responsible for antioxidant and PAF-antagonist activity are present in consistent, clinically validated concentrations. Only standardized extracts have been used in the RCTs demonstrating cognitive benefits; raw leaf supplements are not interchangeable with these formulations.

### Is NeuroShield (Ginkgo biloba extract) safe to take during pregnancy or while breastfeeding?

Ginkgo biloba extract is generally not recommended during pregnancy and breastfeeding due to limited safety data in these populations. While traditionally used, standardized extracts like NeuroShield have not been adequately studied in pregnant or nursing women, so it is best to consult a healthcare provider before use in these situations.

### What makes standardized Ginkgo biloba extract more effective than non-standardized forms?

Standardized NeuroShield products guarantee consistent levels of active compounds—specifically flavonol glycosides and terpene trilactones—ensuring reliable potency from batch to batch. Non-standardized Ginkgo products can vary significantly in bioactive content, making standardized extracts more predictable for neuronal protection and cognitive support.

### Is NeuroShield (Ginkgo biloba extract) suitable for children or elderly individuals?

While elderly individuals may benefit from NeuroShield for age-related cognitive support, use in children is not well-established and should only occur under medical guidance. The elderly are generally considered an appropriate population for Ginkgo supplementation, though dosing adjustments and monitoring for drug interactions with other medications are important considerations.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*